Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Update

Siemens Healthineers AG (OTCMKTS:SMMNY) saw a significant drop in short interest in June. As of June 30th, there was short interest totaling 51,538 shares, a drop of 55.6% from the June 15th total of 116,151 shares. Based on an average daily volume of 345,299 shares, the days-to-cover ratio is presently 0.1 days.

Siemens Healthineers Price Performance

OTCMKTS SMMNY traded down $0.54 on Tuesday, hitting $19.54. The stock had a trading volume of 117,677 shares, compared to its average volume of 165,301. The business’s fifty day moving average price is $19.89 and its 200 day moving average price is $22.40. Siemens Healthineers has a 52-week low of $19.32 and a 52-week high of $28.92.

Siemens Healthineers (OTCMKTS:SMMNY) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The business had revenue of $6.68 billion for the quarter, compared to analyst estimates of $6.96 billion.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.